We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Edwards Lifesciences, QIWI, Lowe's, The Home Depot and Amazon.com highlighted as Zacks Bull and Bear of the Day
Read MoreHide Full Article
For Immediate Release
Chicago, IL – August 24, 2017 – Zacks Equity Research highlights Edwards Lifesciences (NYSE:EW – Free Report) as the Bull of the Day QIWI plc (NASDAQ:(QIWI - Free Report) – Free Report)as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Shares of Lowe’s (NYSE:LOW – Free Report), The Home Depot, Inc. (NYSE:HD – Free Report) and Amazon.com (NASDAQ:(AMZN - Free Report) – Free Report).
Edwards Lifesciences(NYSE:(EW - Free Report) – Free Report), the $24 billion global leader in structural heart disease innovations, is once again a Zacks #1 Rank Strong Buy after reporting strong Q2 results and improved guidance for Q3 that prompted analysts to raise EPS estimates.
Edwards Lifesciences’ second-quarter sales grew 10.9% to $841.8 million, beating the consensus. Underlying sales increased 15.3%, including the impact of German customers stocking shelves for additional inventory of the SAPIEN 3 valve in anticipation of a potential supply interruption resulting from recent intellectual property litigation.
Revenues were driven by considerable growth in the company's primary solution, the transcatheter aortic valve replacement (TAVR) device, which, as the name implies, is a specialized collapsible valve that can be inserted into a patient's heart via a catheter, thus eliminating the need for major invasive surgery.
This innovation is especially welcome for older or at-risk heart patients whose doctors are concerned about the dangers of open heart surgery.
In 2011, the FDA approved the Sapien valve invented by Edwards as the first approved transcatheter aortic valve prosthesis.
By the end of 2015, nearly 55,000 procedures had been performed.
Bear:
QIWI plc (NASDAQ:(QIWI - Free Report) – Free Report) is an $800 million provider of next generation payment services primarily in Russia. The company has an integrated network that enables payment services across physical, online and mobile channels.
The QIWI network enables merchants to accept cash and electronic payments from virtual wallets, and operates cash-collecting terminals and kiosks. QIWI plc is based in Moscow and went public in 2013.
The reason that QIWI is in the cellar of the Zacks Rank is that EPS estimates recently took a hit after a resurgence in the first half of the year.
In July, analysts began lowering estimates when the stock was still trading above $20. And that was when QIWI became a Zacks #4 Rank Sell.
In Q2, QIWI was a Zacks #1 Rank Strong Buy as the estimates moved up. If you had followed the Rank then, you would have caught the move in the stock from $17 to $25.
And last month, the Rank identified what many would have thought was a buying opportunity on the pullback to $20 as really a new sell signal. The new consensus EPS for 2017 of $1.11 represents negative "growth" of -13%, even while revenue estimates still reflect 19% growth to $198 million.
And while next year's EPS forecast of $1.44 would be 30% growth, investors should wait and watch for the estimates to turn back up before investing in QIWI.
Shares of Lowe’s (NYSE:LOW – Free Report) fell 6% in morning trading on Wednesday after the company reported worse-than-expected second quarter fiscal 2017 results.
Lowe’s reported adjusted earnings of $1.57 per share, missing the Zacks Consensus Estimate of $1.62. The company also reported revenue of $19.495 billion, missing our estimate of $19.523 billion, although the company still grew 6.76% year-over-year.
Lowe’s poor earnings contrast sharply with their rival The Home Depot, Inc. (NYSE:HD – Free Report). Home Depot has been one of the few retail stocks that had a great earnings report this fiscal quarter. The company beat our earnings estimates while its comparable store sales were up about 6.3% year-over-year. In comparison, Lowe’s said their comparable sales rose only 4.5%.
In order to improve sales, Lowe’s plans to increase the number of hours their employees work in order to provide additional customer service face-to-face. “We believe this is the right strategy to more fully capitalize on strong traffic trends in what we believe is a supportive macroeconomic backdrop for home improvement,” said Robert Niblock, Lowe’s CEO.
However, because workers will need to be paid more, the company’s bottom line will take a hit. Lowe’s has lowered its guidance for the full fiscal year to $4.20 to $4.30 a share, well below our estimate of $4.62 per share.
This strategy could pay off in the long run, though. Customer service remains a large incentive for customers to choose Lowe’s over online retailers, like Amazon.com (NASDAQ:AMZN – Free Report), in order to get assistance on home improvements. “This is one category in retail where service really matters,” Brian Nagel, an analyst for Oppenheimer & Co., told CNBC this morning.
Lowe’s remains a Zacks Rank #3 (Hold), with a VGM score of ‘A.’
4 Surprising Tech Stocks to Keep an Eye on
Tech stocks have been a major force behind the market’s record highs, but picking the best ones to buy can be tough. There’s a simple way to invest in the success of the entire sector. Zacks has just released a Special Report revealing one thing tech companies literally cannot function without. More importantly, it reveals 4 top stocks set to skyrocket on increasing demand for these devices. I encourage you to get the report now – before the next wave of innovations really take off.
Every day, the analysts at Zacks Equity Research select two stocks that are likely to outperform (Bull) or underperform (Bear) the markets over the next 3-6 months.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous analyst coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year. See these high-potential stocks free >>.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Edwards Lifesciences, QIWI, Lowe's, The Home Depot and Amazon.com highlighted as Zacks Bull and Bear of the Day
For Immediate Release
Chicago, IL – August 24, 2017 – Zacks Equity Research highlights Edwards Lifesciences (NYSE:EW – Free Report) as the Bull of the Day QIWI plc (NASDAQ:(QIWI - Free Report) – Free Report)as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Shares of Lowe’s (NYSE:LOW – Free Report), The Home Depot, Inc. (NYSE:HD – Free Report) and Amazon.com (NASDAQ:(AMZN - Free Report) – Free Report).
Here is a synopsis of all three stocks:
Bull of the Day:
Edwards Lifesciences(NYSE:(EW - Free Report) – Free Report), the $24 billion global leader in structural heart disease innovations, is once again a Zacks #1 Rank Strong Buy after reporting strong Q2 results and improved guidance for Q3 that prompted analysts to raise EPS estimates.
Edwards Lifesciences’ second-quarter sales grew 10.9% to $841.8 million, beating the consensus. Underlying sales increased 15.3%, including the impact of German customers stocking shelves for additional inventory of the SAPIEN 3 valve in anticipation of a potential supply interruption resulting from recent intellectual property litigation.
Revenues were driven by considerable growth in the company's primary solution, the transcatheter aortic valve replacement (TAVR) device, which, as the name implies, is a specialized collapsible valve that can be inserted into a patient's heart via a catheter, thus eliminating the need for major invasive surgery.
This innovation is especially welcome for older or at-risk heart patients whose doctors are concerned about the dangers of open heart surgery.
In 2011, the FDA approved the Sapien valve invented by Edwards as the first approved transcatheter aortic valve prosthesis.
By the end of 2015, nearly 55,000 procedures had been performed.
Bear:
QIWI plc (NASDAQ:(QIWI - Free Report) – Free Report) is an $800 million provider of next generation payment services primarily in Russia. The company has an integrated network that enables payment services across physical, online and mobile channels.
The QIWI network enables merchants to accept cash and electronic payments from virtual wallets, and operates cash-collecting terminals and kiosks. QIWI plc is based in Moscow and went public in 2013.
The reason that QIWI is in the cellar of the Zacks Rank is that EPS estimates recently took a hit after a resurgence in the first half of the year.
In July, analysts began lowering estimates when the stock was still trading above $20. And that was when QIWI became a Zacks #4 Rank Sell.
In Q2, QIWI was a Zacks #1 Rank Strong Buy as the estimates moved up. If you had followed the Rank then, you would have caught the move in the stock from $17 to $25.
And last month, the Rank identified what many would have thought was a buying opportunity on the pullback to $20 as really a new sell signal. The new consensus EPS for 2017 of $1.11 represents negative "growth" of -13%, even while revenue estimates still reflect 19% growth to $198 million.
And while next year's EPS forecast of $1.44 would be 30% growth, investors should wait and watch for the estimates to turn back up before investing in QIWI.
The Zacks Rank will let you know.
Additional content:
Here’s Why Lowe’s (LOW - Free Report) Stock Fell Wednesday
Shares of Lowe’s (NYSE:LOW – Free Report) fell 6% in morning trading on Wednesday after the company reported worse-than-expected second quarter fiscal 2017 results.
Lowe’s reported adjusted earnings of $1.57 per share, missing the Zacks Consensus Estimate of $1.62. The company also reported revenue of $19.495 billion, missing our estimate of $19.523 billion, although the company still grew 6.76% year-over-year.
Lowe’s poor earnings contrast sharply with their rival The Home Depot, Inc. (NYSE:HD – Free Report). Home Depot has been one of the few retail stocks that had a great earnings report this fiscal quarter. The company beat our earnings estimates while its comparable store sales were up about 6.3% year-over-year. In comparison, Lowe’s said their comparable sales rose only 4.5%.
In order to improve sales, Lowe’s plans to increase the number of hours their employees work in order to provide additional customer service face-to-face. “We believe this is the right strategy to more fully capitalize on strong traffic trends in what we believe is a supportive macroeconomic backdrop for home improvement,” said Robert Niblock, Lowe’s CEO.
However, because workers will need to be paid more, the company’s bottom line will take a hit. Lowe’s has lowered its guidance for the full fiscal year to $4.20 to $4.30 a share, well below our estimate of $4.62 per share.
This strategy could pay off in the long run, though. Customer service remains a large incentive for customers to choose Lowe’s over online retailers, like Amazon.com (NASDAQ:AMZN – Free Report), in order to get assistance on home improvements. “This is one category in retail where service really matters,” Brian Nagel, an analyst for Oppenheimer & Co., told CNBC this morning.
Lowe’s remains a Zacks Rank #3 (Hold), with a VGM score of ‘A.’
4 Surprising Tech Stocks to Keep an Eye on
Tech stocks have been a major force behind the market’s record highs, but picking the best ones to buy can be tough. There’s a simple way to invest in the success of the entire sector. Zacks has just released a Special Report revealing one thing tech companies literally cannot function without. More importantly, it reveals 4 top stocks set to skyrocket on increasing demand for these devices. I encourage you to get the report now – before the next wave of innovations really take off.
See Stocks Now>>
About the Bull and Bear of the Day
Every day, the analysts at Zacks Equity Research select two stocks that are likely to outperform (Bull) or underperform (Bear) the markets over the next 3-6 months.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous analyst coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year. See these high-potential stocks free >>.
Get the full Report on EW – FREE
Get the full Report on QIWI – FREE
Get the full Report on LOW – FREE
Get the full Report on HD – FREE
Get the full Report on AMZN – FREE
Follow us on Twitter: https://twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.